Meeder Advisory Services’s Moderna MRNA Stock Holding History

Meeder Advisory Services’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$412K	Buy	8,118 +904	+13%	+$42.2K	0.02%	437
2025 Q4	$213K	Buy	+7,214	New	+$196K	0.01%	631
2024 Q3	–	Sell	-3,447	Closed	-$409K	–	564
2024 Q2	$409K	Buy	3,447 +1,516	+79%	+$192K	0.03%	354
2024 Q1	$206K	Buy	+1,931	New	+$195K	0.02%	430
2023 Q4	–	Sell	-1,997	Closed	-$206K	–	435
2023 Q3	$206K	Sell	1,997 -1,372	-41%	-$153K	0.03%	392
2023 Q2	$409K	Sell	3,369 -825	-20%	-$110K	0.04%	310
2023 Q1	$644K	Buy	4,194 +166	+4%	+$27.4K	0.07%	235
2022 Q4	$724K	Buy	+4,028	New	+$659K	0.09%	206

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Meeder Advisory Services's MRNA Position: Q1 2026 in Review

Meeder Advisory Services increased its Moderna (MRNA) stake by 13% in Q1 2026, buying an estimated $42.2K and bringing the position to 8,118 shares worth $412K. The position accounts for 0.02% of the portfolio, ranked #437.

Meeder Advisory Services first reported a position in MRNA in Q4 2022 and has held it in 8 quarters since. The position peaked at $724K in Q4 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Meeder Advisory Services held 8,118 shares of Moderna worth $412K as of Q1 2026.
Meeder Advisory Services bought 904 Moderna shares in Q1 2026, an estimated $42.2K.
Moderna made up 0.02% of Meeder Advisory Services's portfolio in Q1 2026, its #437 holding.
Meeder Advisory Services first reported a position in Moderna in Q4 2022 and has held it in 8 quarters since.
Meeder Advisory Services's Moderna position peaked at $724K in Q4 2022.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.